Gaush Meditech Ltd (HKG:2407)
Hong Kong · Delayed Price · Currency is HKD 4.585
-0.105 (-2.24%)
Sep 11, 2026, 3:50 PM HKT
Gaush Meditech Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 648 | 1,197 | 1,454 | 5,593 | 7,626 | - | |
Market Cap Growth | -49.58% | -17.63% | -74.01% | -26.66% | - | - |
Enterprise Value | 718 | 1,304 | 1,332 | 5,510 | 10,110 | - |
Last Close Price | 4.58 | 8.24 | 9.39 | 33.22 | 45.31 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.55 | 11.19 | 14.79 | 29.26 | - | - |
Forward PE | - | 15.09 | 15.09 | 20.04 | - | - |
PS Ratio | 0.42 | 0.78 | 0.96 | 3.61 | 5.38 | - |
PB Ratio | 0.34 | 0.63 | 0.86 | 2.99 | 4.54 | - |
P/TBV Ratio | 1.23 | 2.64 | 3.69 | 11.30 | 23.77 | - |
P/FCF Ratio | - | 8.86 | 14.67 | 23.71 | 35.69 | - |
P/OCF Ratio | - | 7.46 | 12.67 | 20.39 | 28.78 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.47 | 0.85 | 0.88 | 3.56 | 7.13 | - |
EV/EBITDA Ratio | 4.09 | 6.59 | 4.97 | 16.34 | 32.89 | - |
EV/EBIT Ratio | 7.19 | 10.41 | 6.44 | 19.75 | 39.39 | - |
EV/FCF Ratio | - | 9.65 | 13.44 | 23.36 | 47.31 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.24 | 0.30 | 0.35 | 0.39 | 0.51 | -4.14 |
Debt / EBITDA Ratio | 2.65 | 2.51 | 2.01 | 2.03 | 2.59 | 8.68 |
Debt / FCF Ratio | - | 4.18 | 5.93 | 3.10 | 4.00 | 19.01 |
Net Debt / Equity Ratio | 0.03 | 0.04 | 0.02 | -0.10 | -0.04 | -3.18 |
Net Debt / EBITDA Ratio | 0.32 | 0.39 | 0.13 | -0.55 | -0.21 | 7.01 |
Net Debt / FCF Ratio | - | 0.57 | 0.36 | -0.79 | -0.31 | 14.59 |
Asset Turnover | 0.53 | 0.53 | 0.53 | 0.51 | 0.49 | 0.56 |
Inventory Turnover | 2.07 | 2.22 | 2.34 | 2.37 | 2.43 | 2.90 |
Quick Ratio | 1.20 | 1.33 | 1.34 | 1.10 | 2.00 | 1.77 |
Current Ratio | 2.35 | 2.40 | 2.25 | 1.56 | 2.69 | 2.47 |
Return on Equity (ROE) | 4.22% | 5.55% | 5.39% | 10.86% | -82.67% | - |
Return on Assets (ROA) | 2.15% | 2.71% | 4.50% | 5.69% | 5.52% | 6.52% |
Return on Invested Capital (ROIC) | 4.21% | 5.29% | 7.04% | 11.96% | 13.30% | 14.02% |
Return on Capital Employed (ROCE) | 4.30% | 5.20% | 9.50% | 13.00% | 10.20% | 12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 13.44% | 8.94% | 6.76% | 3.42% | -5.18% | - |
FCF Yield | - | 11.29% | 6.82% | 4.22% | 2.80% | - |
Dividend Yield | 6.54% | - | 3.19% | 3.31% | - | - |
Payout Ratio | - | 41.35% | 160.78% | - | - | - |
Buyback Yield / Dilution | 2.21% | 1.83% | 0.14% | -52.69% | -1.16% | 9.03% |
Total Shareholder Return | 8.75% | 1.83% | 3.34% | -49.38% | -1.16% | 9.03% |